Graduate Jobs Fair at NUI Galway

Graduate Jobs Fair at NUI Galway-image

Monday, 28 September 2015

Over 70 actively recruiting companies across all industries will feature at the NUI Galway Graduate Jobs Fair on Tuesday, 6 October from 12.30-4pm in the Bailey Allen Hall. The Graduate Jobs Fair will showcase graduate employment opportunities for students and graduates from all disciplines, with a diverse number of fields such as accountancy, IT, law, science, retail, civil and public sectors, and consultancy. Major local employers such as Medtronic, SAP, Enterprise Ireland and Smyths will attend, in addition to international companies including Abbott, SITA Inc., Pepper Asset Servicing and Gerson Lehrman Group. Emma Goode, Employment Officer with NUI Galway’s Career Development Centre, said: “Demand for NUI Galway graduates across all academic disciplines remains high, reflecting on their excellent employability status. There will also be an opportunity to get information on postgraduate programmes available in NUI Galway.” Emma also has some advice for those attending the Fair: “Don’t forget your main objective on the day is to secure your first graduate job. Many graduate employers now recruit graduates from all academic disciplines so don’t be misled by an organisation’s name – they may have the perfect graduate opportunity for you! Prepare for the fair. Research the companies you are interested in and the type of opportunities they have available. Have something to say when you approach a stand and be confident, positive, enthusiastic and professional. Arrive with a ‘can do’ attitude and be prepared to network!” Details on participating exhibitors is available from     -Ends-

>> Read full story about Graduate Jobs Fair at NUI Galway

An Taoiseach Opens New Research Centres to Benefit Frontline Patient Care

An Taoiseach Opens New Research Centres to Benefit Frontline Patient Care -image

Monday, 28 September 2015

The clinical translational research facility will be a significant development for health care and medical technology sector in Ireland Enable the best researchers and health professionals to carry out studies that will change people’s lives for the better Currently over 100 clinical trials underway involving people with cancer, diabetes, cardiovascular disease, amongst others NUI Galway will open the Lambe Institute for Translational Research and HRB Clinical Research Facility at University Hospital Galway today. The co-location of these two facilities in one building on hospital grounds will mean basic laboratory research conducted in the translational research facility can be evaluated in clinical trials in the clinical research facility and ultimately benefit patients faster. Some examples of the types of studies undertaken in the two facilities will include: Predicting risk of breast cancer due to inherited characteristics Stem cell trials to help improve blood flow in legs of diabetic patients and prevent amputation Clinical trials in blood cancer patients to establish whether new treatments can be combined with existing treatment for better outcomes. How implantable medical devices can provide new solutions for patients Officially opening the building today, An Taoiseach said: “I am delighted to celebrate the opening of this new clinical and translational facility made up of the Lambe Institute for Translational Research and the Health Research Board Clinical Research Facility. This project represents a truly innovative partnership between NUI Galway, Health Research Board, Saolta University Health Care Group, and HSE supported by private philanthropy through Galway University Foundation. Ireland is recognised as an emerging global hub for the ‘medtech’ sector. Galway is at the very heart of this development and NUI Galway is the powerhouse for much of this progress. In July 2011, I officially opened a new Engineering building at NUI Galway. Last February I launched the Biomedical Sciences building. Today we open a unique clinical and translational research facility. Taken together these three facilities complete an ecosystem of education, research, innovation and healthcare in the West of Ireland. This latest facility represents the point where research and health care meet – where “bench” meets “bedside”. The advances made by researchers and clinicians in this facility will undoubtedly lead to better frontline health outcomes and will ultimately improve patients’ lives.” NUI Galway President, Dr Jim Browne, said, “Today is a milestone in the development of medicine at NUI Galway. NUI Galway has given strategic priority to the development of biomedical engineering science. Over the past two decades we have invested heavily in this area, with major new research facilities on our campus. Our researchers advance scientific knowledge to address health challenges. Here in this building that scientific knowledge is being developed into novel treatments, which are then carefully applied in the clinical setting and tested in clinical trials led by NUI Galway.” Dr Graham Love, Chief Executive of the Health Research Board highlights, “The HRB Clinical Research Facility is not just a building - it is a game changer. Turning health research discoveries into real benefits for people’s health and patient care doesn’t happen by itself. This HRB facility will enable the best researchers and health professionals to carry out studies that will change people’s lives for the better. The HRB CRF will provide a safe place for patients to take part in clinical trials and access the latest treatments. It will be a centre of learning for young researchers and health professionals– so we are investing in our future. And it will also create opportunities for partnership between the health system, academia and industry that we know will support health system innovation and economic development.” Commenting, Maurice Power, CEO, Saolta University Health Care Group said, “This exciting new facility brings together leading-edge medical research directly to the bedside of patients at University Hospital Galway and the wider Hospital Group.  For our patients, the facility will provide inpatient and outpatient beds, a minor operations room, endoscopy, endocrine and cardiorespiratory suites, a phlebotomy room and a biometrics unit.  As well as its primary function in benefiting our patients it will also allow our Hospital Group attract and retain the highest calibre of medical professionals." Philanthropy has played a central role in this development. Galway University Foundation acknowledged the support of philanthropic donors, in particular, Dr Ronan and Ann Lambe, the 50 plus member of the Corrib Medical Network, Bank of Ireland and the National Breast Cancer Research Institute. Speaking at the launch Dr Ronan Lambe, said:  “It is a great privilege for my wife and I to be associated with such a state of the art facility which will enhance the reputation of NUI Galway as a centre of excellence for Bio Medical Research.”    The proximity of the University to UHG will enable direct patient access and collaborative trial input from the hospital Oncology/Haematology Clinical Trials Unit. The CRF will ensure that patients in the West and North West of Ireland have access to a number of new cancer therapies that would otherwise not have been available to them. Clinical trials are active in the treatment of melanoma, multiple myeloma, mantel cell lymphoma, breast, prostate, lung, gastrointestinal and gynaecological cancers. Some Examples of trials that are underway at the two facilities Case Study 1 – Predicting risk of breast cancer due to inherited characteristics The incidence of breast cancer is increasing and the role genetics play is not yet fully understood for the majority of women. We calculate that less than 10% of women with a strong family history have an abnormality in the BRCA1 or BRCA 2 genes which are known to be associated with a risk of developing breast cancer. According to Professor Michael Kerin, Interim Director of the Lambe Institute for Translational Research, “In the West of Ireland we have a very high incidence of breast cancer and examining the genes that cause this cancer is a key research priority and has contributed to multiple international studies, including one which identified 74 new genetic changes associated with breast cancer. The HRB-Clinical Research Facility will allow new trials to be developed around these genetic targets.”   Case study 2 Preventing amputation in patients with diabetes mellitus Patients with Diabetes Mellitus can often experience limited blood flow to the leg. Many patients present with gangrene, pain at rest or ulceration in the leg. While bypass of the obstruction is possible in some patients amputation may be required for one in every three patients with this complication. In fact an amputation occurs every 30 seconds somewhere in the world due to diabetes mellitus and thus new treatments are urgently required. A new study, which will take place across the HRB Clinical Research Facility, the Lambe Institute for Translational Research and University Hospital Galway will take stem cells isolated from patients’ bone marrow, grow them in a specially designed laboratory at NUI Galway and then inject them into the leg in the dedicated clinical research space. This research is a first-in-person study which aims to assess the safety and feasibility of this approach and is funded by the Health Research Board and Science Foundation Ireland. According to lead researcher, Professor Tim O Brien, Dean, College of Medicine, Nursing and Health Sciences, NUI Galway and Consultant Endocrinologist at University Hospital Galway, “The aim is to see if injections of stem cells along the leg will improve blood flow and prevent the need for amputation in these patients. This first-in-person study is designed to assess the safety and feasibility of this approach and if this is demonstrated larger studies will be required to assess efficacy. Having a dedicated laboratory provided by the Lambe Institute in close proximity to the HRB Clinical Research Facility on hospital grounds transforms our ability to do this research and provide our patients with early access to trials in a safe environment. The provision of the new facility along with recent capital developments in Galway including the Biomedical Science Research Building, the Centre for Cell Manufacturing Ireland and the Galway Blood and Tissue Establishment provides the complete infrastructure to perform studies of stem cell therapy in Ireland.” Case study 3 Tackling blood cancer Multiple myeloma is the second most common blood cancer and it has a particularly high incidence in Ireland. It is important to look for new therapies to treat people who relapse or are unresponsive to existing treatment. Another clinical trial which will take place across these two new facilities will test the efficacy of a new drug in combination with existing treatments to see if it improves outcomes for these patients. Professor Michael O’Dwyer, HRB Clinician Scientist at NUI Galway says, “Based on promising results of an initial trial, we are now moving forward to test the impact of a stronger dose of the new drug in combination with existing treatments. If this is successful, the treatment should be available to Irish patients sometime later this year. The availability of labs and clinical facilities in one place is fantastic. It creates a situation where we have the optimum facilities, skills and patients which means we are very competitive in attracting international trials. This is important because it has been shown that regardless of the outcome of trials, patients who get to participate in trials do better than those who don’t.” Case Study 4 Prevention is better than cure – Diabetes in pregnancy Diabetes in pregnancy, known as Gestational Diabetes Mellitus (GDM) poses many risks to both mother and baby. The prevalence of GDM is 12% of all pregnancies in Ireland but varies considerably across Europe with prevalence of up to 20% reported for some populations.  It is known that if women adopt and maintain a healthy lifestyle during pregnancy, they can help create optimal health outcomes for both mother and the baby they are carrying. However, there is currently little evidence that actually shows the benefits of preventing of diabetes in pregnancy.  In order to build evidence in this area Professor Fidelma Dunne Consultant Endocrinologist, NUI Galway and Galway University Hospital is the Irish Principal Investigator on a new European randomised controlled trial called DALI. “This study is comparing the impact of diet, exercise, taking Vitamin D, and various combinations of these lifestyle changes, on reducing the risk of developing gestational diabetes in at-risk pregnant women. The HRB Clinical Research Facility is one of 11 centres around Europe where this EU FP7 funded study is taking place.” She continues, ‘It is essential that we increase the evidence base and highlight the importance of preventing and managing diabetes in pregnancy for mother and baby.’ According to Professor Martin O’Donnell, Director of the HRB Clinical Research Facility at NUI Galway, “In tandem with our focus on improving clinical care of patients, a clear priority for the HRB Clinical Research Facility is to improve health at a population level, through prevention of disease. At the HRB-CRFG we are conducting a range of studies that will inform optimal approaches to preventing stroke, heart attack and dementia in populations, with a focus on nutrition, blood pressure, obesity, diabetes and lifestyle behaviours.” Case Study 5 - Predicting responses to chemotherapy in breast cancer patients The era of personalised medicine means that chemotherapy is now more targeted towards specific cancer subtypes. However the prediction of response to common chemotherapeutic agents still poses a problem for clinicians. It would be beneficial to be able to predict treatment response by a simple blood test and save women, who are not getting the benefit from chemotherapy, the trauma of continued treatment and instead give them the option of an alternative and better regimen. According to Professor Michael Kerin, Interim Director of the Lambe Institute for Translational Research, "We have exciting data from trials which suggest that specific biomarkers (microRNAs) circulating in the bloodstream can predict response to treatment in breast cancer. As a result of this we may be able to select better therapies for patients. The research questions raised will be translated into new clinical trials in conjunction with the HRB-Clinical Research Facility.” If you would like more information on the work of the HRB Clinical Research Facility, please email -ENDS- Osclaíonn an Taoiseach Ionaid nua Taighde a rachaidh chun tairbhe Príomhchúram Othar Forbairt shuntasach do na hearnálacha cúraim sláinte agus teicneolaíochta leighis in Éirinn a bheidh sa tsaoráid taighde aistrithigh agus chliniciúil Cuirfear ar chumas na dtaighdeoirí agus an lucht gairme sláinte is fearr tabhairt faoi staidéir a chuirfidh feabhas ar shaol daoine Sa bhreis ar 100 triail chliniciúil ar siúl faoi láthair le daoine a bhfuil ailse, diaibéiteas, galar cardashoithíoch ag gabháil dóibh Inniu osclóidh OÉ Gaillimh Ionad Lambe don Taighde Aistritheach agus Saoráid Taighde Chliniciúil HRB in Ospidéal na hOllscoile, Gaillimh. De bhrí go mbeidh an dá shaoráid seo in aon fhoirgneamh amháin ar thailte an ospidéil beifear in ann an buntaighde saotharlainne a dhéanfar sa tsaoráid taighde aistrithigh a mheas sna trialacha cliniciúla sa tsaoráid taighde chliniciúil agus dá bhrí sin feicfidh othair an tairbhe i bhfad níos sciobtha. I measc na gcineálacha staidéar a dtabharfar fúthu sa dá shaoráid beidh: -          An baol a bhaineann le hailse chíche a fhorbairt mar gheall ar thréithe dúchais a réamh-mheas -          Trialacha gascheall chun sreabhadh fola i gcosa othar diaibéiteach a fheabhsú d'fhonn teascadh a sheachaint -          Trialacha cliniciúla in othar a bhfuil ailse fola ag gabháil dóibh le déanamh amach an féidir cóireálacha nua a chur le seanchóireálacha chun torthaí níos fearr a fháil -          Conas is féidir le feistí leighis ionchlannaithe réitigh nua a chur ar fáil d'othair Dúirt an Taoiseach inniu agus é ag oscailt an fhoirgnimh go hoifigiúil: “Tá an-áthas orm ceiliúradh a dhéanamh ar oscailt na saoráide nua seo áit a bhfuil Institiúid Lambe don Taighde Aistritheach agus Saoráid Taighde Chliniciúil an Bhoird Taighde Sláinte.  Léiríonn an tionscadal seo comhpháirtíocht thar a bheith nuálach idir OÉ Gaillimh, an Bord Taighde Sláinte, Grúpa Cúraim Sláinte Ospidéil Saolta, agus Feidhmeannacht na Seirbhíse Sláinte; comhpháirtíocht atá maoinithe ag daonchairdeas príobháideach trí Fhondúireacht Ollscoil na Gaillimhe. Samhlaítear Éire mar mhol domhanda atá ag teacht chun cinn go láidir san earnáil leighis-teicneolaíochta. Tá Gaillimh i gcroílár na forbartha seo agus tá OÉ Gaillimh mar lárionad do chuid mhór den dul chun cinn seo. I mí Iúil 2011, d'oscail mé an foirgneamh nua Innealtóireachta go hoifigiúil in OÉ Gaillimh.  I mí Feabhra seo caite d'oscail mé an foirgneamh Eolaíochta Bithleighis. Inniu osclaímid saoráid uathúil taighde chliniciúil agus aistrithigh.  Nuair a chuirtear le chéile na trí shaoráid seo tá éiceachóras iomlán againn d'oideachas, taighde, nuálaíocht agus cúram sláinte in Iarthar na hÉireann. Seasann an tsaoráid is déanaí seo don phointe ina dtagann taighde agus cúram sláinte le chéile – an pointe ina dtagann an “teoiric” agus an “cleachtadh” le chéile.  De bharr na hoibre a dhéanfaidh taighdeoirí agus cliniceoirí sa tsaoráid seo is cinnte go mbeidh torthaí sláinte príomha níos fearr ann agus ar deireadh cuirfear feabhas ar shaol na n-othar.” Bhí an méid seo a leanas le rá ag an Dr Jim Browne, Uachtarán OÉ Gaillimh, “Is buaicphointe i bhforbairt an leighis in OÉ Gaillimh atá sa lá inniu.  Tá tús áite straitéiseach tugtha ag OÉ Gaillimh d'fhorbairt na heolaíochta innealtóireachta bithleighis.  Le scór bliain anuas tá infheistíocht láidir déanta againn sa réimse seo, agus saoráidí móra taighde ar an gcampas mar thoradh air seo. Cuireann ár dtaighdeoirí eolas eolaíoch chun cinn d'fhonn aghaidh a thabhairt ar dhúshláin sláinte.  San fhoirgneamh seo táthar ag déanamh cóireálacha nua as an eolas eolaíoch seo, agus ansin tá siad sin á gcur i bhfeidhm sa suíomh cliniciúil agus á dtástáil i dtrialacha cliniciúla faoi stiúir OÉ Gaillimh.” Dúirt an Dr Graham Love, Príomhfheidhmeannach an Bhoird Taighde Sláinte, “Tá níos mó ná foirgneamh i gceist le Saoráid Taighde Chliniciúil HRB, is athrú iomlán ar chur chuige atá ann. Tá obair mhór i gceist le fionnachtana taighde sláinte a aistriú isteach i bhfíorbhuntáistí do shláinte daoine agus do chúram othar. Cuirfidh an tsaoráid HRB seo ar chumas na dtaighdeoirí agus na ngairmithe sláinte is fearr dá bhfuil ann staidéir a dhéanamh a athróidh saol daoine chun feabhais. Beidh áit shábháilte ag othair sa tsaoráid HRB chun páirt a ghlacadh i dtrialacha cliniciúla agus chun teacht ar na cóireálacha is nuaí. Lárionad foghlama do thaighdeoirí óga agus do ghairmithe sláinte a bheidh ann – táimid ag déanamh infheistíochta inár dtodhchaí. Chomh maith leis sin, cruthóidh sé deiseanna comhpháirtíochta idir an córas sláinte, an lucht acadúil agus an tionscal a thacóidh le nuálaíocht sa chóras sláinte agus le forbairt gheilleagrach. Dúirt Maurice Power, Príomhfheidhmeannach, Grúpa Cúraim Sláinte Ospidéil Saolta, “Tugann an tsaoráid nua seo taighde ceannródaíoch leighis chuig an othar sa leaba in Ospidéal na hOllscoile, Gaillimh agus sa Ghrúpa Ospidéil níos leithne.  Cuirfidh an tsaoráid na nithe seo a leanas ar fáil dár n-othair: leapacha in-tí agus eisothair, seomra do mhionobráidí, seomraí ionscópachta, inchríneacha agus cardairiospráideacha, seomra fleibeatóime agus aonad bithmhéadrachta.  Chomh maith le feidhmiú go príomha ag déanamh leasa dár n-othair cuirfidh sé ar chumas an Ghrúpa Ospidéil na gairmithe leighis is fearr a mhealladh agus a choinneáil.” Bhí ról lárnach ag an daonchairdeas san fhorbairt seo.  Thug Fondúireacht Ollscoil na Gaillimhe aitheantas don tacaíocht a fuarthas ó dheontóirí daonchairdiúla, go háirithe an Dr Ronan agus Ann Lambe, breis is 50 ball de Líonra Leighis na Coiribe, Banc na hÉireann agus an Institiúid Náisiúnta don Taighde ar Ailse Chíche.  Ag labhairt dó ag an seoladh dúirt an Dr Ronan Lambe:  “Is iontach an phribhléid dom féin agus do mo bhean a bheith bainteach le saoráid den scoth a chuirfidh go mór le cáil OÉ Gaillimh mar ionad barr feabhais don Taighde Bithleighis.”    Mar gheall go bhfuil an Ollscoil chomh gar don Ospidéal beidh teacht ag taighdeoirí go díreach ar othair agus beidh ionchur comhoibríoch trialach ag an Aonad Trialacha Cliniciúla Oinceolaíochta/Haemaiteolaíochta san ospidéal. Cinnteoidh an tSaoráid Taighde Chliniciúil go mbeidh teacht ag othair in Iarthar agus in Iarthuaisceart na hÉireann ar theiripí nua ailse nach mbeadh ar fáil dóibh murach an tsaoráid seo. Tá trialacha cliniciúla ar siúl faoi láthair chun cóir leighis a chur ar fáil in aghaidh: meileanóma, mialóma iolrach, liomfóma ceall maintlín, alise chíche, phróstataigh, scamhóige, ghastraistéigeach agus ghínéiceolaíoch. Roinnt samplaí de na trialacha atá ar bun sa dá shaoráid   Cás-staidéar 1 – An baol a bhaineann le hailse chíche a fhorbairt mar gheall ar thréithe dúchais a réamh-mheas Tá níos mó cásanna den ailse chíche ag teacht chun cinn agus níltear cinnte fós faoin ról atá ag géinitic i bhformhór na mban. Áirímid go bhfuil níos lú ná 10% de mhná le stair láidir teaghlaigh a bhfuil mínormáltacht sna géinte BRCA1 nó BRCA 2, géinte atá bainteach leis an mbaol a bhaineann le hailse chíche a fhorbairt. Dar leis an Ollamh Michael Kerin, Stiúrthóir Gníomhach Institiúid Lambe don Taighde Aistritheach, “In Iarthar na hÉireann feictear líon an-ard d'ailse chíche agus is príomhthosaíocht taighde é na géinte is cúis leis an ailse seo a scrúdú agus tá go leor staidéir idirnáisiúnta déanta sa réimse seo, staidéar amháin a d'aithin 74 athrú nua géiniteach bainteach le hailse chíche. Tabharfaidh Saoráid Taighde Chliniciúil HRB deis dúinn trialacha nua a fhorbairt bunaithe ar na spriocanna géiniteacha seo.”   Cás-staidéar 2 – Teascadh in othair le diaibéiteas mellitus a sheachaint Is minic go gcuireann sreabhadh teoranta fola sa chos as d'othair a bhfuil diaibéiteas mellitus ag gabháil dóibh. Go hiondúil bíonn morgadh, pian agus tú ar do shuaimhneas nó othrasú sa chos ag cur as d'othair. Cé gur féidir seach-chonair a dhéanamh ar an mbacainn i gcásanna áirithe, tá an baol ann go mbeidh teascadh i gceist d'othar amháin as triúr a mbaineann an aimhréidh seo dóibh. Go deimhin, tarlaíonn teascadh chuile 30 soicind in áit éigin ar domhan de bharr diaibéiteas mellitus, agus is ar an mbunús sin a theastaíonn cóireálacha nua go géar. Déanfaidh staidéar nua – a bheidh ar bun idir Saoráid Taighde Chliniciúil HRB, Institiúid Lambe don Taighde Aistritheach agus Ospidéal na hOllscoile, Gaillimh – a bhaineann le gaschealla a thógáil ó smior na n-othar, iad a fhás i saotharlann speisialta ar leith in OÉ Gaillimh agus iad a instealladh sa chos ar an láthair taighde chliniciúil faoi leith.  Tá an taighde seo ar an gcéad staidéar a bhaineann leis an taighde daonna agus é mar aidhm aige an cur chuige ó thaobh sábháilteachta agus indéantachta a mheas; tá an taighde á mhaoiniú ag an mBord Taighde Sláinte agus ag Fondúireacht Eolaíochta Éireann.  Dar leis an bpríomhthaighdeoir, an tOllamh Tim O Brien, Déan, Coláiste an Leighis, an Altranais agus na nEolaíochtaí Sláinte, OÉ Gaillimh agus Comhairleoir le hInchríneolaíocht in Ospidéal na hOllscoile, Gaillimh, “Is é an aidhm atá leis an staidéar seo go bhfeicfí an gcuideoidh na hinstealltaí de ghaschealla sa chos leis an sreabhadh fola a fheabhsú agus teascadh a sheachaint sna hothair seo. Tá an chéad staidéar a bhaineann le taighde daonna curtha ar bun chun sábháilteacht agus indéantacht an chuir chuige a mheas agus má léirítear gur amhlaidh atá, beidh gá le taighde breise ar scála níos mó chun a éifeachtúlacht a mheas.  Cuireann an tsaotharlann speisialta in Institiúid Lambe atá cóngarach do Shaoráid Taighde Chliniciúil HRB ar thailte an ospidéil go mór lenár gcumas an taighde seo a chur i gcrích agus luath-thrialacha i dtimpeallacht shábháilte a sholáthar dár n-othar. Soláthraíonn an tsaoráid nua, móide na forbairtí caipitil reatha i nGaillimh ar a n-áirítear foirgneamh Taighde Eolaíochta Bithleighis, an tIonad don Chillmhonarú in Éirinn agus Bunaíocht Fola agus Fíocháin na Gaillimhe, an t-infreastruchtúr iomlán d'fhonn staidéar ar theiripe gascheall a bhaint amach in Éirinn.”   Cás-staidéar 3 – Dul i ngleic le hailse fola Tá mialóma iolrach ar an dara hailse fola is coitianta le líon an-ard cásanna den chineál ailse seo in Éirinn. Is den tábhacht go lorgófaí teiripí nua chun cóireáil a chur ar dhaoine a dtagann athiompú orthu nó iad siúd nach n-oibríonn an chóir leighis atá ar fáil faoi láthair dóibh. Déanfaidh triail chliniciúil eile, a bheidh ar bun sa dá shaoráid nua seo, dianscrúdú ar a éifeachtúla is atá an chóir leighis nua le feiceáil an mbíonn torthaí níos fearr le fáil nuair a dhéantar cóireálacha nua a chur le seanchóireálacha. Thug an tOllamh Michael O’Dwyer, Eolaí Cliniceora HRB in OÉ Gaillimh le fios: “Bunaithe ar dhea-thorthaí trialach tosaigh, táimid anois ag déanamh tástáil ar an tionchar atá ag dáileog níos láidre den druga nua in éineacht le seanchóireálacha. Má éiríonn leis seo, ba chóir go mbeadh an chóir leighis ar fáil do mhuintir na hÉireann níos deireanaí sa bhliain. Tá sé thar cionn go bhfuil na saotharlanna agus na saoráidí cliniciúla seo ar fáil faoi aon díon amháin. Buntáiste mór é na hothair, na saoráidí agus na scileanna ardchaighdeáin seo a bheith ar fáil ar an láthair chéanna agus léiríonn sé go bhfuilimid thar a bheith iomaíoch ó thaobh trialacha idirnáisiúnta a mhealladh. Tá tábhacht ar leith leis seo mar go léirítear, beag beann ar thorthaí na dtrialacha, go n-éiríonn níos fearr le hothair a bhíonn rannpháirteach sna trialacha i gcomparáid leo siúd nach mbíonn.”   Cás-staidéar 4 – Is fearr cosc ná leigheas – Diaibéiteas le linn toirchis D'fhéadfadh go leor rioscaí a bheith i ndán do mháthair agus leanbh mar gheall ar dhiaibéiteas le linn toirchis, nó Diaibéiteas Mellitus le linn Toirchis (GDM). Bíonn GDM i gceist in 12% de gach toircheas in Éirinn, le rátaí éagsúla ar fud na hEorpa agus tuairiscítear go bhféadfadh GDM a bheith i gceist i suas le 20% de thoirchis i bpobail ar leith.  Tuigtear má chloíonn mná le stíl shláintiúil mhaireachtála an fhad is atá siad ag iompar, gur féidir leo dea-thorthaí sláintiúla a bhaint amach dóibh féin agus don leanbh atá á iompar acu. Mar sin féin, is beag fianaise atá ar fáil i láthair na huaire a léiríonn na buntáistí a bhaineann le diaibéiteas le linn toirchis a sheachaint.  Chun críche fianaise a bhailiú sa réimse seo tá an tOllamh Fidelma Dunne, Comhairleoir le hInchríneolaíocht in OÉ Gaillimh agus Ospidéal na hOllscoile, Gaillimh ag feidhmiú mar Phríomhthaighdeoir na hÉireann ar thriail nua Eorpach atá randamaithe agus rialaithe dar teideal DALI. “Díríonn an staidéar seo ar an laghdú is féidir le haiste bia, aclaíocht, Vitimín D a ghlacadh, agus meascáin éagsúla de na hathruithe saoil seo a dhéanamh ar an mbaol do mhná sa chatagóir ardriosca diaibéiteas le linn toirchis a fhorbairt. Tá Saoráid Taighde Chliniciúil HRB ar cheann d'aon ionad déag ar fud na hEorpa ina bhfuil an staidéar maoinithe FP7 AE ar siúl.” Mhínigh sí “go bhfuil sé riachtanach go gcuirfimis leis an mbonn fianaise agus go dtairngneoimis aird ar an tábhacht a bhaineann le diaibéiteas le linn toirchis a chosc agus a bhainistiú don mháthair agus don leanbh.” Dar leis an Ollamh Martin O’Donnell, Stiúrthóir Shaoráid Taighde Chliniciúil HRB in OÉ Gaillimh, “I gcomhar lenár bhfócas ar chúram cliniciúil othar a fheabhsú, tá sé mar phríomhthosaíocht ag Saoráid Taighde Chliniciúil HRB cúram sláinte ag leibhéal pobail a fheabhsú, trí chosc a chur ar ghalair. Tá foireann Shaoráid Taighde Chliniciúil HRB ag stiúradh réimse staidéar óna mbeidh eolas úsáideach ar fáil ó thaobh na gcur chuige is fearr i dtaca le stróc, taom croí agus néaltrú a chosc i measc an phobail, trí dhíriú ar iompraíochtaí cothaithe, brú fola, diaibéiteas agus stíl mhaireachtála.” Cás-staidéar 5 –  An tionchar a bhíonn ag ceimiteiripe ar othair a bhfuil ailse chíche ag gabháil dóibh a réamh-mheas Le ré an leighis shainiúil glactar leis go bhfuil ceimiteiripe ar fáil a dhíríonn ar fhochineálacha ailse ar leith. É sin ráite cruthaíonn an tionchar a bhaineann le gníomhaithe ceimiteiripeacha a réamh-mheas fadhb do na cliniceoirí. Bheadh sé ina bhuntáiste dá bhféadfaí an tionchar a bhíonn ag cóireálacha a réamh-mheas trí thástáil fola simplí a dhéanamh agus mná, nach ndéanann an cheimiteiripe aon mhaitheas dóibh, a chosaint ó chóireáil leanúnach a fháil, agus rogha eile de réim mhalartach níos fearr a chur ar fáil dóibh. Dar leis an Ollamh Michael Kerin, Stiúrthóir Gníomhach Institiúid Lambe don Taighde Aistritheach, “Tá eolas spéisiúil bailithe againn ó thrialacha a léiríonn gur féidir le bithchomharthaí sóirt ar leith (miocrRNAs) atá sa chóras fola an fhreagairt chóireála i gcásanna ailse chíche a réamh-mheas. Mar thoradh air seo, beimid ábalta teiripí níos fearr a roghnú dár n-othair. Déanfar na ceisteanna taighde a thagann chun cinn a aistriú isteach ina dtrialacha taighde nua i gcomhar le Saoráid Taighde Chliniciúil HRB.” -CRÍOCH-  

>> Read full story about An Taoiseach Opens New Research Centres to Benefit Frontline Patient Care

Seolfaidh OÉ Gaillimh Suirbhé Teangeolaíochta ar Oileáin Árann

Seolfaidh OÉ Gaillimh Suirbhé Teangeolaíochta ar Oileáin Árann-image

Monday, 28 September 2015

Seolfaidh OÉ Gaillimh Suirbhé Teangeolaíochta ar Oileáin Árann  ‘An staidéar is cuimsithí ar aon chanúint Ghaeilge go dtí seo’ Seolfaidh Iar-Chláraitheoir agus Iar-Leas-Uachatarán na hOllscoile, an tOllamh Nollaig Mac Congáil, saothar an Dr Séamas Ó Direáin, Suirbhé ar an nGaeilge Labhartha in Oileáin Árann, Co. na Gaillimhe, ar Aoine 9 Deireadh Fómhair ag 1.30in in Téatar Uí Chearbhalláin, Áras na Gaeilge, OÉ Gaillimh. Saothar saoil de chuid theangeolaí de shliocht Árann, an Dr Séamas Ó Direáin as California, is ea Suirbhé ar an nGaeilge Labhartha in Oileáin Árann, Co. na Gaillimhe, saothar a cruthaíodh thar tréimhse 25 bliain. Tráth dá raibh sé i mbun taighde ar theangacha na hAfraice sa Chéinia sna 1970í, thosnaigh an Dr Ó Direáin – a mbeidh 77 bliain slánaithe aige an mhí seo chugainn – ar an nGaeilge a fhoghlaim ó dheoraithe as Éirinn. Agus os cionn 40 bliain caite ó shin, tá ríméad ar an Dr Ó Direáin go mbeidh a Shuirbhé ar theanga dhúchais a mhuintire ar fáil anois ar líne agus saor in aisce ón 9 Deireadh Fómhair 2015 ar aghaidh. Staidéar mionchruinn canúineolaíochta ar an nGaeilge labhartha in Oileáin Árann atá sa Suirbhé seo. Díríonn sé go speisialta ar na difríochtaí tíreolaíocha agus sóisialta a bhaineann leis na glúnta, idir shean agus óg, leis na hinscní (fir/buachaillí agus mná/cailíní), agus le leibhéil oideachais. Den chéad uair riamh i gcás aon teanga in aon áit ar domhan, déantar anailís chuimsitheach shochtheangeolaíochta agus canúineolaíochta ar raon leathan éagsúlachtaí a mhaireann san fhoghraíocht agus sa ghramadach. I gcás an oileáin is mó, Árainn (nó Inis Mór, mar a thugtar air amanta), tá mioneolas sa Suirbhé i dtaobh éagsúlachtaí foghraíochta, gramadaí agus an stóir focal go fiú ar leibhéal na mbailte fearainn. Adeir an tOllamh Kevin Scannell, Ollamh le Matamaitic agus Ríomheolaíocht, Ollscoil St Louis: “Is léir go bhfuil éacht déanta ag Séamas Ó Direáin lena chuid taighde teangeolaíochta ar na canúintí Gaeilge in Oileáin Árann.  Is dócha gurb é seo an staidéar is cuimsithí ar aon chanúint Ghaeilge go dtí seo, agus tá sé go hiontach go mbeidh scoláirí agus taighdeoirí in ann teacht ar an anailís agus ar na bunsonraí go léir ar líne i bhfoirm inchuardaithe leictreonach." Adeir an Dr John Walsh, Léachtóir Sinsearach le Gaeilge, OÉ Gaillimh: “Baineann tábhacht náisiúnta agus idirnáisiúnta leis an saothar canúineolaíochta seo le Séamas Ó Direáin. Cuireann sé go mór lenár n-eolas ar chanúineolaíocht chomhaimseartha na Gaeilge trí chéile agus sáraíonn sé aon staidéar eile a deineadh ar chanúintí Árann roimhe seo. Is mór iad na deiseanna eile taighde a eascraíonn as agus tá áthas orm gur in Ollscoil na hÉireann, Gaillimh a bheidh sé lonnaithe feasta.” Féach an Suirbhé -Críoch-   NUI Galway to Launch Linguistic Survey of the Aran Islands ‘Most comprehensive study of any dialect of Irish completed to date’ Former NUI Galway Registrar and Deputy President, Professor Nollaig Mac Congáil will launch Dr Séamas Ó Direáin’s A Survey of Spoken Irish in the Aran Islands, Co. Galway on Friday, 9 October at 1.30pm in Áras na Gaeilge, NUI Galway. Created over a period of 25 years, A Survey of Spoken Irish in the Aran Islands, Co. Galway represents the life’s work of Californian linguist Dr Séamas Ó Direáin, whose grandparents emigrated from Inis Mór to Boston over 100 years ago. Dr Ó Direáin, who turns 77 this October, first started learning Irish from expats in Kenya in the 1970s where he was researching African languages. Over 40 years later, he is delighted to make his Survey available for free and online from 9 October. The Survey constitutes a highly detailed, almost microscopic, micro-dialectological study of spoken Irish in the Aran Islands, focusing on geographical and social variation linked to generations (older and younger age-groups), genders (male and female), and level of education. It provides for the first time ever, for any language anywhere in the world, an extensive analysis linguistic variations of the islands. In the case of the largest of the three islands, Inis Mór, the Survey includes detailed information on phonological, grammatical and lexical variation at the level of individual townlands. Professor Kevin Scannell, Professor of Mathematics and Computer Science, St Louis University, said: “Séamas Ó Direáin’s linguistic research on the dialects of Irish spoken in the Aran Islands is clearly a major achievement. This is probably the most comprehensive study of any dialect of Irish completed to date, and it is wonderful that scholars and researchers will now have searchable online access to all of the data and analysis.” Dr John Walsh, Senior Lecturer in Irish at NUI Galway, said: “This dialectological work by Séamas Ó Direáin is of national and international importance. It adds greatly to our knowledge of the dialectology of Irish in general and surpasses all over previous studies of the dialects of Aran. Many other research possibilities can emerge from it and I am delighted that it will be housed at the NUI Galway from now on.” For further information or to view the Survey visit -Ends-

>> Read full story about Seolfaidh OÉ Gaillimh Suirbhé Teangeolaíochta ar Oileáin Árann

New Community Exercise Programme Proves Popular

New Community Exercise Programme Proves Popular-image

Monday, 28 September 2015

Places still available for fitness programme   Monday, 28 September, 2015: Places are still available for a new community exercise programme, Exercise4Healthdesigned for those who due to health issues are reluctant to engage in exercise. The programme is a collaboration between NUI Galway, Croí and the Kingfisher Fitness Club. Croí’s Specialist Physiotherapist, Denise Dunne said: “This new initiative is proving very popular and we have capacity to cater for many more people who are interested in joining us.” Being physically active prevents and helps control a multitude of health problems, especially, heart disease, stroke, diabetes and obesity. Exercise4Health provides a locally accessible opportunity for anyone looking to commence a safe and beneficial exercise programme supervised by professional trainers and exercise specialists. The programme is ideally suited to anyone trying to reduce weight or improve their overall health and wellbeing. The six-week rolling exercise programme is specially designed to suit all levels of current fitness and prior to enrolling for the classes, participants will be provided with a medical assessment to ascertain their fitness level. This new programme, led by expert cardiac physiotherapists/exercise specialists from Croí and delivered in conjunction with the fitness team at Kingfisher Club, will provide participants with: An assessment of their existing fitness level and a personalised plan for improvement Fitness classes delivered at a level to suit everyone Weekly heart-rate monitoring and personal progress tracking A motivating and enjoyable fitness programme which can be continued at home and which if followed will provide a measurable improvement in fitness levels Professor Terry Smith, Professor of Biomedical Engineering Science at NUI Galway said, “This exciting new partnership between NUI Galway, Croí and the Kingfisher Fitness Club aims to provide a community based exercise initiative which will significantly help to improve the health and wellbeing of people suffering from a range of chronic illnesses. Participants will only undertake exercise activities that suit their individual abilities and needs. Thebenefits are not just improved physical health, but meeting other participants and the fitness team at the Kingfisher Club also provides a great social outlet.” The Exercise4Health programme will take place in the Kingfisher Fitness Club at NUI Galway from 12pm-1pm every Thursday. For further information or to book a place on this exciting new programme call Croí on 091 544310. -Ends-  

>> Read full story about New Community Exercise Programme Proves Popular

Irish Researchers Leading the Way for Cardiac Defect Repairs

Irish Researchers Leading the Way for Cardiac Defect Repairs-image

Tuesday, 29 September 2015

NUI Galway researcher is author of paper contributing to the design of an innovative device to close heart defects without placing patients on bypass Researchers, including four Irish researchers, while based at the Wyss Institute, Brigham and Women’s Hospital, and Boston Children’s Hospital have jointly designed a fundamentally different way to implant an innovative patch to close a heart tissue defect that eradicates the need to place a patient on bypass. Their work was published recently in Science Translational Medicine, and features as the cover article. Ellen Roche, PhD and a graduate from the Biomedical Engineering Program at NUI Galway was the first author of the paper. Roche completed the work published in Science Translational Medicine during her PhD at Harvard University and is a current research fellow at NUI Galway under Professor Peter McHugh, working on a project in Biomedical Engineering in the area of novel cardiac drug delivery device development. The PhD scholar is a future faculty member at Massachusetts Institute of Technology. The researchers invented a flexible, UV light-containing catheter that can be inserted through a vessel, and directed to the defect within the heart. Two balloons, one on either side of the hole, are inflated when the catheter is in place. One of the balloon’s surfaces has a mirror-reflecting quality that reflects UV light from a small internal fibre optic to cure the adhesive. All components of the device are soft and can deflate for easy loading and removal through the outer catheter shaft. Dr Roche said: “This system has proven successful in closing tissue defects in a number of experiments described in the paper. As well as correcting heart defects, the patch and the catheter can be used in a variety of situations - for example, abdominal hernia repair or peptic ulcer closure.” The other Irish authors who contributed to the research with Dr Roche were Professor Conor Walsh, joint senior author and a Trinity College and Massachusetts Institute of Technology graduate who runs the Harvard Biodesign Lab, Dr Eoin O’Cearbhaill, Lecturer at UCD and a Biomedical Engineering and PhD graduate from NUI Galway, and William Whyte, a current PhD student at Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI). View the paper on Science Translational Medicine website: -Ends-

>> Read full story about Irish Researchers Leading the Way for Cardiac Defect Repairs

Comhdháil ar Litríocht agus ar Chultúr na Gaeilge 2015

Comhdháil ar Litríocht agus ar Chultúr na Gaeilge 2015-image

Wednesday, 30 September 2015

Beidh an ceathrú comhdháil is fiche ar Litríocht agus ar Chultúr na Gaeilge á reáchtáil ag Roinn na Gaeilge, Ollscoil na hÉireann Gaillimh, ar an Aoine agus ar an Satharn 9-10 Deireadh Fómhair. Is í an chomhdháil seo an t-aon chomhdháil bhliantúil ollscoile dá leithéid a reachtáiltear go hiomlán trí Ghaeilge. Is iad An tOllamh Barry McCrea, Ollscoil Notre Dame, An Dr Caitríona Ó Dochartaigh, Coláiste na hOllscoile, Corcaigh, agus Darach Mac Con Iomaire, Stiúrthóir agus Scríbhneoir aoichainteoirí Chomhdháil 2015. Mar chuid den chomhdháil, seolfaidh an tOllamh Nollaig Mac Congáil an saothar teangeolaíochta Suirbhé ar Ghaeilge Labhartha Árann, Co. na Gaillimhe, leis an Dr Séamas Ó Direáin. Beidh an suirbhé cuimsitheach seo ar chanúintí Árann ar fáil saor in aisce ar líne ar Ina theannta sin, seolfar an leabhar Cruinneas le hAntain Mac Lochlainn agus Amhráin na Midhe: Athchóiriú agus Aistriúcháin le Lesa Ní Mhunghaile. Beidh na seoltaí ar siúl in Áras na Gaeilge, OÉ, Gaillimh. Deir an Dr Rióna Ní Fhrighil, Cathaoirleach an choiste eagraithe: “Comhdháil ar leith í seo a chothaíonn an scoláireacht agus an taighde trí mheán na Gaeilge. Cé go mbeidh go leor réimsí éagsúla taighde á bplé i rith na comhdhála, beidh béim ar leith ar an gceangal idir litríocht na Gaeilge agus an Eoraip i mbliana.” Tá clár iomlán na comhdhála ar fáil ar   -Críoch-

>> Read full story about Comhdháil ar Litríocht agus ar Chultúr na Gaeilge 2015

Countdown to Maths Week 2015 at NUI Galway

Countdown to Maths Week 2015 at NUI Galway-image

Wednesday, 30 September 2015

NUI Galway will present a series of mathematics appreciation events for the upcoming Maths Week 2015, running from the 10-18 October. Lecturers from the School of Mathematics, Statistics and Applied Mathematics at NUI Galway will provide interactive talks and workshops at local schools, launch the nationwide secondary schools competition PRISM (PRoblem Solving for Irish Second Level Mathematics), and organise a series of public talks on the University campus. Robin Wilson, Professor of Geometry at Gresham College, London, will deliver two talks on Friday, 16 October. The first talk, ‘Stamping through Mathematics’ is aimed at primary school students from 5th and 6th class. It will cover the whole history of mathematics in one hour, and is illustrated with 250 attractive (and sometimes bizarre!) postage stamps from around the world, featuring mathematics and mathematicians. The second talk, ‘Lewis Carroll in Numberland’ is aimed at secondary school students and will offer a look at the mathematical life of Charles Dodgson (Lewis Carroll), the author of Alice’s Adventures in Wonderland and Through the Looking-Glass. Professor Graham Ellis from the School of Mathematics, Statistics and Applied Mathematics at NUI Galway said: “Maths Week is the biggest festival of mathematics in the world, and we are always eager to participate. It provides a great opportunity to engage with pupils and show the beauty of mathematics and its importance in education and in the wider world.” On Thursday, 15 October, the School of Mathematics will launch and host the nationwide maths competition PRISM (PRoblem solving for Irish Second level Mathematics). PRISM can be run in each interested secondary school at junior and/or senior levels. Registered Maths teachers can download a full package (problem sheets, answer keys, and more) for their classes. The website generates numerical and graphical summary statistics of student performances in real time and identifies the top-performing schools and individuals. Talks with Professor Robin Wilson will take place on Friday, 16 October in the IT Building, Theatre IT250 at NUI Galway. ‘Stamping through Mathematics’ will take place at 11am and ‘Lewis Carroll in Numberland’ will take place at 1pm. To arrange school visits by lecturers contact and to book seats for public lectures on campus email To take part in PRISM visit and for all other events taking place across the country during Maths Week visit -Ends-

>> Read full story about Countdown to Maths Week 2015 at NUI Galway

CÚRAM PhD Student Awarded First Prize for best Podium Presentation at European Biomaterials Conference

CÚRAM PhD Student Awarded First Prize for best Podium Presentation at European Biomaterials Conference-image

Wednesday, 30 September 2015

NUI Galway student wins award for research presentation on modifying brain dysfunctions in patients suffering from Parkinson’s disease CÚRAM PhD student Juhi Samal has been awarded first prize out of 300 entries, for her presentation on ‘Delivery of Neurotrophic Factors to the Brain using Fibrin-based Hollow Microsphere Reservoirs'. The prize was awarded at the 27th European Society for Biomaterials (ESB) Conference held in Krackow, Poland this month. ESB conferences attract over 1,000 delegates every year. The annual conference allows scientists and engineers from different disciplines to discuss current issues concerning the latest research in the field of biomaterials. The conference sessions included topics ranging from biomaterials for regenerative medicine, nanotechnology to stem cells application and smart systems for various therapies. Juhi Samal was awarded the Hardiman Fellowship in 2013 and is undertaking her PhD at the Centre for Research in Medical Devices (CÚRAM), based at NUI Galway under Professor Abhay Pandit and Dr Eilis O’Dowd. One of CÚRAM’s key research areas focuses on developing solutions for neurodegenerative disease. Juhi’s research is investigating delivery of neurotrophic factors to modify neuronal dysfunctions in patients suffering from Parkinson’s disease. “Neurotrophic factors are proteins that can promote the initial growth and development of neurons in the central and peripheral nervous systems and have also been shown to be capable of slowing, halting or reversing neuronal degeneration in laboratory and pre-clinical settings” explains Juhi Samal. “However their therapeutic potential is limited by their short half-life. My research has been investigating a biomaterials-based intervention, which protects these proteins, allowing them to survive for longer and be released where and when needed in a more controlled fashion.” Professor Abhay Pandit, Director of CÚRAM at NUI Galway, congratulated Juhi on her award and commented, “CÚRAM has attracted a wide pool of talented researchers. With the talent and technical tools we have at our disposal, our aim is to take the fruits of our research and develop it to the stage where these medical device products can be brought to clinical trial in Ireland. We want to see results, not only for healthcare, but also for job creation and the economy.” Supported by Science Foundation Ireland and industry funding, CÚRAM aims to radically improve health outcomes for patients by developing implantable ‘smart’ medical devices. It will develop these devices through strong clinical collaborations with industry partners and hospital groups to enable their rapid translation to clinics. -Ends-

>> Read full story about CÚRAM PhD Student Awarded First Prize for best Podium Presentation at European Biomaterials Conference

NUI Galway maintains position and improves score in Times Higher Rankings

NUI Galway maintains position and improves score in Times Higher Rankings-image

Thursday, 1 October 2015

Continuous improvement for University in both THE and QS rankings NUI Galway has maintained its position in the Times Higher Education (THE) World University Rankings for 2015-16, remaining within the 251-300 range and improving on previous scores across most categories. Once again NUI Galway performed strongly in the international outlook score and research citations score as well as improving scores across most other metrics. NUI Galway was the only Irish university to maintain or increase its position in the two main international rankings in 2014, having recently increased to 271st in the world in the QS World University Rankings 2015/2016, one of just two Irish universities to improve their standing in this year’s league table. Last month Thomson Reuters ranked four outstanding researchers from NUI Galway among the ‘World’s Most Influential Scientific Minds: 2015’ an increase on the three researchers cited last year. The 3000 international academics named on the list earned their distinction by publishing the highest number of articles that rank among those most frequently cited by fellow researchers. More individuals were listed from NUI Galway than from any other Irish university. The continuous improvement has been attributed to a concerted approach by the University in developing world-class research in specific fields, NUI Galway President Dr Jim Browne explained: “This is a major improvement for NUI Galway and reflects a sustained upward trend in these very competitive global rankings. This consistent improvement in NUI Galway’s THE World University Rankings this year is an affirmation of our very focused approach to developing our international reputation in a select set of research areas. These areas of activity underpin our growing international research reputation and continue to attract researchers, scholars and international partners. To maintain or increase our position in both the 2015 THE World University Rankings and the recently published QS World University Rankings, it is beyond doubt that our position globally is on the rise. Despite significant cuts in overall funding at third-level in Ireland and increased student numbers, our University has gone against the tide to secure a continued improvement in these very competitive rankings.” The Times Higher Education league table of the world’s top universities is based on 13 separate performance indicators covering all of the core missions of a world class university; teaching, research, knowledge transfer and international outlook. The survey also includes one of the world’s largest academic reputation survey, with more than 10,000 academics asked to rate the world’s best universities for the 2015/16 ranking. Phil Baty, editor of the THE World University Rankings: “The Times Higher Education World University Rankings, now in their 12th year, apply rigorous standards, using tough global benchmarks across all of a global research university’s key missions – teaching, research, knowledge transfer and international outlook. The results are trusted by students and their families, academics, university leaders and governments. For NUI Galway to make 251-300 in the world is an outstanding achievement to be celebrated.” The Times Higher Education (THE) World University Rankings for 2015-16 is available to view online at: -ends- OÉ Gaillimh san áit chéanna le scór níos airde i Ranguithe an Times Higher Feabhas leanúnach don Ollscoil sna ranguithe THE agus QS Tá a seasamh coinnithe ag OÉ Gaillimh i Ranguithe Ollscoile an Domhain de chuid Times Higher Education (THE) do 2015-16, í ag fanacht sa réimse 251-300 agus d'ardaigh sí a scóir i bhformhór na gcatagóirí. D'éirigh thar cionn arís le OÉ Gaillimh sa dearcadh idirnáisiúnta agus sna tagairtí taighde agus i bhformhór na méadrachtaí eile. Ba í OÉ Gaillimh an t-aon ollscoil in Éirinn a rinne dul chun cinn sa dá phríomhrangú idirnáisiúnta in 2014, bhain sí amach an 271ú háit i Ranguithe Ollscoile QS an Domhain 2015/2016 le gairid, agus gan ach ollscoil amháin eile in Éirinn ag ardú i dtábla sraithe na bliana seo. An mhí seo caite, d'fhógair Thomson Reuters ceathrar taighdeoirí den scoth as OÉ Gaillimh i measc ‘the World’s Most Influential Scientific Minds: 2015’, ardú ar an triúr taighdeoirí a fógraíodh anuraidh. Ainmníodh 3,000 duine acadúil idirnáisiúnta ar an liosta as ucht an líon is mó alt a fhoilsiú a dtagraíonn taighdeoirí eile dóibh. Ainmníodh níos mó daoine as OÉ Gaillimh ná as aon ollscoil eile in Éirinn. Mhínigh Uachtarán OÉ Gaillimh, an Dr Jim Browne, go ndearnadh an dul chun cinn seo mar gheall ar chur chuige comhaontaithe na hOllscoile taighde den scoth a fhorbairt i réimsí sonraithe: “Is dul chun cinn ollmhór é seo do OÉ Gaillimh agus léiríonn sé ardú leanúnach sna ranguithe domhanda seo atá thar a bheith iomaíoch. Is dearbhú é an t-ardú leanúnach i mbliana ar sheasamh OÉ Gaillimh i Ranguithe Ollscoile an Domhain de chuid THE ar an gcur chuige thar a bheith dírithe atá againn i leith ár gcáil idirnáisiúnta a fhorbairt i réimsí áirithe taighde. Tacaíonn na réimsí gníomhaíochtaí seo lenár gcáil idirnáisiúnta taighde atá i mbun forbartha agus meallann siad taighdeoirí, scoláirí agus comhpháirtithe idirnáisiúnta. Ó tharla go ndearnamar dul chun cinn arís i Ranguithe Ollscoile an Domhain de chuid THE 2015 agus i Ranguithe Ollscoile QS an Domhain a foilsíodh le gairid, tá sé ríshoiléir go bhfuil ár stádas domhanda ag dul ó neart go neart. In ainneoin na gciorruithe suntasacha sa mhaoiniú trí chéile ag an tríú leibhéal in Éirinn agus méadú ar líon na mac léinn, tá an Ollscoil s’againne ar a mine géire le dul chun cinn leanúnach a dheimhniú sna ranguithe seo atá thar a bheith iomaíoch.” Tá tábla sraithe an Times Higher Education de na hollscoileanna is fearr ar domhan bunaithe ar 13 tháscaire feidhmíochta ar leith a chlúdaíonn gach croímhisean a bheadh ag ollscoil den scoth; teagasc, taighde, aistriú eolais agus dearcadh idirnáisiúnta. Tá ceann de na suirbhéanna is mó ar domhan maidir le cáil acadúil áirithe sa suirbhé seo chomh maith. Fiafraíodh de bhreis is 10,000 duine acadúil na hollscoileanna is fearr a rátáil do rangú 2015/16. Dúirt Phil Baty, eagarthóir Ranguithe Ollscoile an Domhain de chuid Times Higher Education: “Cuireann Ranguithe Ollscoile an Domhain de chuid Times Higher Education, le 12 bhliain as a chéile, caighdeáin ghéara i bhfeidhm, ag úsáid tagarmharcanna dochta domhanda i leith na gcroímhisean a bhaineann le hollscoil taighde dhomhanda – teagasc, taighde, aistriú eolais agus dearcadh idirnáisiúnta. Tá muinín ag mic léinn, a dteaghlaigh, lucht acadúil, ceannairí ollscoile agus rialtais as na torthaí. Ó tharla go bhfuil OÉ Gaillimh sa chatagóir 251-300 ar domhan is mór an t-éacht é sin agus is fiú go mór é a cheiliúradh.” Tá Ranguithe Ollscoile Times Higher Education (THE) 2015-16 le feiceáil ar líne ag: -críoch-

>> Read full story about NUI Galway maintains position and improves score in Times Higher Rankings

August 2015

NUI Galway Phd student awarded scholarship from the European Molecular Biology Organization

NUI Galway Phd student awarded scholarship from the European Molecular Biology Organization-image

Tuesday, 4 August 2015

Final year PhD student Dilip Thomas has been awarded a travel fellowship by the European Molecular Biology Organization (EMBO), to advance his research in the area of vascular repair and regeneration. Dilip is carrying out his PhD at NUI Galway, supervised by Professor Abhay Pandit and Professor Timothy O’Brien of CÚRAM, the Science Foundation Ireland funded Centre for Research in Medical Devices.  Dilip’s project looks specifically at the development of a functionalised stem cell delivery platform for critical limb ischemia. Critical limb ischemia is a serious form of peripheral arterial disease and is caused by atherosclerosis, the hardening and narrowing of the arteries over time due to the build-up of fatty deposits called plaque and is a chronic condition that results in severe pain, even while resting. Complications of poor circulation can include sores and wounds that won't heal and complications of critical limb ischemia can result in amputation. The research goal at CÚRAM is to engineer a unique ‘finger-print’ microenvironment, also called ‘niche’, for the modulation of stem cell behaviour to promote new blood vessel formation. The long-term goal is to translate pre-clinical success to a viable therapeutic alternative for the treatment of ‘no option’ critical limb ischemia patients to allow amputation-free survival. The fellowship opportunity at Professor Marchetti-Deschmann’s analytical laboratory, Technical University of Vienna, Austria will help dissect the key molecular factors and events that drive tissue repair and regeneration with help of state-of-the-art tissue imaging mass-spectrometers. EMBO is an organisation of more than 1,700 leading researchers that promotes excellence in the life sciences. The major goals of the organisation are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work. “The EMBO fellowship is a great step in Dilip’s career as a researcher and reflects the high standard of research being carried out at CÚRAM in ‘smart’ medical device development at all levels” said Professor Abhay Pandit, Director of CÚRAM. “The key aim of our work is to radically improve health outcomes for patients suffering from chronic illnesses, including CLI.” CÚRAM is a national research centre advancing R&D in the medical device sector. Supported by Science Foundation Ireland and industry partners, CÚRAM enhances Ireland's standing as a major hub for the global medical devices industry. ENDS

>> Read full story about NUI Galway Phd student awarded scholarship from the European Molecular Biology Organization

<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 > >>

Press member?

Visit our press centre

Connect & share